• SENSEX 76,917.85
    1,225.07 (+1.62%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,814.50 1,878.00(%)
  • Jio Platforms
    1,440.80 1,490.00(%)
  • Bharti Airtel
    2,080.70 2,174.70(%)
  • Reliance Industries
    1,307.00 1,611.20(%)
  • BLS Polymers
    285.25 285.25(%)
  • Solar Industries
    20,860.00 22,630.05(%)
  • Multi Comm. Exc.
    3,537.00 3,537.00(%)
  • Aegis Logistics
    1,253.90 1,528.00(%)
  • SBI
    961.35 933.85(%)
  • HDFC Bank
    725.70 1,017.90(%)
  • Oil India
    451.30 395.75(%)
  • Garden Reach Sh.
    2,235.00 3,338.90(%)
  • Divi's Lab.
    10,035.00 10,035.00(%)
  • M & M Fin. Serv.
    267.15 415.00(%)
  • Sagility
    41.98 35.82(%)
  • SFC Enviro.
    424.85 424.85(%)
  • Mankind Pharma
    2,523.70 2,640.30(%)
  • M & M
    2,910.95 3,840.00(%)
  • Kanohar Elect.
    1,165.90 1,210.00(%)
  • Laurus Labs
    2,252.50 913.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sat Kartar Life Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 93343.0
  • ISIN : INE0NB801022
126.50 -1 (-0.43%)
  • As on 04 Nov 2026 (EOD)

  • Today’s Low

    126.50

  • Today’s High

    130.90

  • Open

    128.00

  • Perv Close

    127.05

  • 52W Low

    110.30

  • 52W High

    219.80

Key Indicators

  • P/E(TTM)

    12.55

  • Mar.Cap (₹Cr.)

    199.81

  • Div & Yield %

    0.55

  • Book Value(₹)

    43.38

  • Debt-Equity Ratio

    -0.43

  • AGM Date

    03-Nov-2026

  • EPS

    10.08

  • P/E Ratio

    12.55

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    199.81

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    15.80

  • BV (₹)

    43.40

  • Sales( ₹ in Cr.)

    193.84

  • NP (in Cr.)

    15.93

  • NP Var(%)

    64.0

  • Div%

    7.0

  • CPS (₹)

    12.20

  • EPS (₹)

    10.10

  • Traded Value (₹ in Lakhs)

    199.81

  • 52 Week High

    219.80

  • 52 Week Low

    110.30

  • Price BSE

    0.0

  • Price NSE

    127.00

  • Market Capital( in Cr.)

    199.81

  • P/C Ratio

    10.40

  • P/E Ratio

    12.60

  • Price Vs.BV

    10.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar
INCOME :            
Sales Turnover 193.84 162.92 127.91 82.97 51.92 -
Excise Duty 0.00 0.00 0.00 0.00 0.00 -
Net Sales 193.84 162.92 127.91 82.97 51.92 -
Other Income 2.42 0.76 0.20 0.01 0.39 -
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 -
Total Income 196.26 163.68 128.11 82.98 52.31 -
EXPENDITURE :            
Raw Materials 13.84 9.00 9.03 4.96 4.35 -
Power and Fuel Cost 2.01 2.02 1.44 0.94 0.55 -
Employee Cost 21.49 26.68 28.58 20.16 9.84 -
Other Manufacturing Expenses 2.08 2.30 2.24 1.84 0.80 -
Selling and Administration Expenses 128.06 107.15 75.82 49.32 33.32 -
Miscellaneous Expenses 1.62 1.55 0.56 0.52 0.75 -
Employee Benefit Expenses 21.49 26.68 28.58 20.16 9.84 -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 -
Total Expenses 169.09 148.69 117.67 77.74 49.62 -
Operating Profit 27.16 14.99 10.44 5.24 2.69 -
Interest 0.51 0.54 0.52 0.48 0.46 -
Gross Profit 26.65 14.45 9.92 4.76 2.23 -
Depreciation 3.31 1.30 1.33 1.32 0.72 -
Profit Before Tax 23.34 13.15 8.59 3.44 1.51 -
Current Tax 5.96 3.53 2.33 0.99 0.17 -
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 -
Deferred Tax 0.13 -0.19 -0.04 -0.06 -0.06 -
Reported Net Profit 17.26 9.82 6.31 2.51 1.39 -
Extraordinary Items 1.33 0.10 0.11 -0.02 -0.04 -
Adjusted Net Profit 15.93 9.72 6.20 2.53 1.43 -
Adjustment below Net Profit 0.00 -6.77 -2.10 0.00 0.00 -
P & L Balance brought forward 9.63 6.63 2.57 0.07 -1.32 -
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 -
Appropriations 1.10 0.05 0.15 0.00 0.00 -
P & L Balance carried down 25.78 9.63 6.63 2.57 0.07 -
Dividend 1.10 0.05 0.15 0.00 0.00 -
Preference Dividend 0.00 0.00 0.00 0.00 0.00 -
Equity Dividend (%) 7.00 7.00 7.00 0.00 0.00 -
Dividend Per Share(Rs) 0.70 0.70 0.70 0.00 0.00 -
Earnings Per Share-Unit Curr 10.96 6.23 22.52 3.58 1.98 -
Earnings Per Share(Adj)-Unit Curr 10.96 6.23 - - - -
Book Value 42.97 32.71 33.69 4.68 1.10 -
Book Value(Adj)-Unit Curr 42.97 32.71 - - - -

Shareholding Pattern

  • Promoter Group

    63.49%

  • Public Share Holding

    36.08%

  • Custodian

    0.43%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 5,712,000 36.16 5,712,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,309,556 27.28 4,309,556 9
Partnership Firms-Indian (Promoter & Group) 6,400 0.04 6,400 1
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 10,027,956 63.49 10,027,956 11
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 122,400 0.77 122,400 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 294,400 1.86 294,400 4
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 416,800 2.64 416,800 5
2] Non Institution
Bodies Corporate 919,416 5.82 919,416 48
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 79,200 0.50 79,200 19
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 80,408 0.51 0 31
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,984,260 12.56 1,984,260 18
Individuals holding nominal share capital up to Rs. 1 lakh 2,089,636 13.23 2,089,636 890
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 99,200 0.63 0 1
Others 0 0.00 0 0
Sub Total 5,282,520 33.44 5,072,512 1,015
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 68,000 0.43 68,000 1
Total Shares held by Custodians and against which Depository Receipts have been issued 68,000 0.43 68,000 1
Grand Total ( A + B + C ) 15,795,276 100.00 15,585,268 1,032

Company Background

Sat Kartar Life LtdPharmaceuticals - Indian - Formulations

  • Sat Kartar Life Ltd
  • BSE Code : 93343.0
  • ISIN : INE0NB801022

  • Incorporation Year

    2012

  • Registered Office

    No.603 6th Floor
    Mercantile House KG Marg, New Delhi,
    Delhi-110001

  • Telephone

    +91 93198 88634

  • FAX

  • Chairman

  • Managing Director

    Ved Prakash

  • Company Secretary

    Sonal Seth

  • Auditor

    Nidhi Bansal & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Skyline Financial Services Pvt
    D-153/A 1st Flr,
    Okhla Industrial Are,Phase-I
    Mumbai - New Delhi-110020

Sat Kartar Life Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sat Kartar Life 126.50 196.26 193.84 11.57 37.44
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77